Question to the smarter kids regarding UKs BLA OK ... The way I understand it is that once a treatment/drug is approved for public use, a doctor is given latitude to prescribe that drug for a different indication. But how would that be applied in the case of a combo-therapy? Does leronlimab have to be administered only in combo form? If so, might that reduce the chance a doctor prescribing it for Covid?
Or more to the point, ifwhen this leads to UK approval for HIV, are there paths or back alleys to LL being prescribed for Covid?